G Portale, J H Peters, C-C Hsieh, J A Hagen, S R DeMeester, T R DeMeester
Division of Thoracic and Foregut Surgery, University of Southern California, 1510 San Pablo Street, Los Angeles, CA 90033, USA.
Surgical endoscopy 2006 FebThe presentation and management of esophageal cancer are changing, as more patients are diagnosed at an earlier stage of the disease in which endoscopic treatment methods may be contemplated. Therefore, we conducted a study to determine whether symptomatic and endoscopic findings can accurately identify node-negative early-stage adenocarcinoma. A total of 213 consecutive patients (171 men and 42 women) with resectable esophageal adenocarcinoma seen from 1992 to 2002 were evaluated. None of these patients received neoadjuvant chemotherapy or radiation therapy. Using a multivariable model, model-based probabilities of early-stage disease (T1 im/sm N0) were calculated for each combination of the following three features: no dysphagia as main symptom at presentation, tumor length
G Portale, J H Peters, C-C Hsieh, J A Hagen, S R DeMeester, T R DeMeester. Can clinical and endoscopic findings accurately predict early-stage adenocarcinoma? Surgical endoscopy. 2006 Feb;20(2):294-7
PMID: 16333557
View Full Text